Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Genetic drugs stories

Oct 30, 2026

Blocking microRNA-31-5p interaction reverses heart scarring and atrial fibrillation in study

Researchers at Baylor College of Medicine and University of Oxford found that blocking a specific molecular interaction between microRNA-31-5p and calcitonin receptor reduced atrial fibrosis and abnormal heart rhythms in mouse models and human cells, offering a potential RNA-based therapeutic strategy for atrial fibrillation.

Oct 30, 2026·2 sources
00
Jul 9, 2026

Dr. Reddy's Delays Generic Ozempic Launch Due to Ingredient Quality Issue

Indian drugmaker Dr. Reddy's Laboratories announced it is delaying commercial production of its generic semaglutide (Ozempic) after discovering an unspecified issue with the active pharmaceutical ingredient in some batches. Shares fell as much as 6.5%.

Jul 9, 2026·2 sources
00
Apr 30, 2026

Supreme Court Hears Arguments on 'Skinny Labeling' Generic Drug Case

The Supreme Court heard oral arguments on a case involving 'skinny labeling' practices that have significant implications for generic drug availability and access, with justices appearing to signal the practice may survive legal challenge.

Apr 30, 2026·2 sources
00

Top claims

  • ▪Human atrial cardiofibroblasts from patients with atrial fibrillation produce twice the amount of microRNA-31-5p compared to non-fibrillating sinus rhythm cells.
  • ▪Treatment with a selective target-site blocker preventing microRNA-31-5p from binding calcitonin receptor mRNA restored calcitonin receptor protein levels in human atrial fibroblasts and mouse models.
  • ▪Inhibition of microRNA-31-5p reduced fibronectin protein levels in human atrial fibroblasts isolated from patients with persistent atrial fibrillation.

Subtopics

Biomedical research1Cardiovascular diseases1Drug development1Drug Policy, Pricing & Approval1FDA regulation & drug policy1Food and nutrition policy1Food safety & additive regulation1Generic drugs & biosimilars1GLP-1 medications1Government and Regulatory Policy1Healthcare access1Healthcare Policy1Heart health1Lifestyle, Wellness and Nutrition1Medical research1Medication Pricing & Affordability1Molecular biology1Public healthcare1Regulatory compliance1Supreme Court1Supreme Court cases1Weight loss medications & GLP-1 drugs1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories